Related Experiment Video
Updated: Sep 13, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
A Rare Case of Symptomatic Pulmonary Infection Caused by Mycobacterium paraffinicum
Huy Vinh1, Nirja Sutaria2, Arun Adlakha3
1Family Medicine, Edward Via College of Osteopathic Medicine, Spartanburg, USA.
Abstract:
Mycobacterium paraffinicum (M. paraffinicum) is a non-tuberculous mycobacterium (NTM) shown to be a human pathogen in recent years. Here, we present a rare case of pulmonary infection caused by M. paraffinicum in a 69-year-old female patient who presented with symptoms, initially thought to be from a chronic obstructive pulmonary disease (COPD) exacerbation. From our literature review, this is a case of M. paraffinicum presenting as a human pathogen. The patient's medical history included COPD, obstructive sleep apnea (OSA), and obesity. Her medical management included inhaled corticosteroid (ICS)/ long-acting beta-agonist (LABA), long-acting muscarinic antagonist (LAMA), and nocturnal continuous positive airway pressure (CPAP) device. For her acute worsening of symptoms, she was treated with oral ciprofloxacin and prednisone for possible COPD exacerbation from presumed pneumonia. However, she showed no improvement in her pulmonary symptoms. Follow-up computed tomography (CT) imaging of the chest showed new scattered "Tree in Bud" opacities. Sputum studies and acid-fast bacilli (AFB) cultures revealed the growth of M. paraffinicum. She was treated with a combination of oral clarithromycin, moxifloxacin, and rifabutin. This case highlights the importance of keeping atypical mycobacteria, such as NTM, as a cause of pulmonary infection in the differential diagnosis, particularly in patients with chronic pulmonary conditions who present with persistent and/or unexplained respiratory symptoms. Early identification is crucial for appropriate treatment to improve patient outcomes.
More Related Videos
07:42A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
Published on: June 5, 2014
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia II: Pathophysiology
Other Pulmonary Disorders